FundedIQ
Artificial Intelligence

Imperagen: Funding, Investors & Team (Sep 2026)

Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.

imperagen.com LinkedIn Manchester, United Kingdom 11-50 employees
Artificial Intelligence (AI) Biotechnology Life Science
Total raised
$6.7M
Rounds
1
Latest
Seed
May 2026

Imperagen has raised $6.7M across 1 funding round on record, the most recent a Seed of $6.7M announced in May 2026.

That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Imperagen Company Profile and Key Stats

Total funding raised
$6.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$6.7M in May 2026
Employees
11-50
reported band
Headquarters
Manchester, United Kingdom

Latest funding round on record: May 2026.

Imperagen Funding Rounds

Date
Round
Amount
Seed
$6.7M

Imperagen Founders and Leadership Team

Name
Role
Contact
Guy Levy
Founder
Locked

Contact details for the Imperagen team: 1 has a LinkedIn profile.

Start 14-day free trial →

Imperagen Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round
5,273
$4.0M
16,485
$3.1M

Imperagen's latest round of $6.7M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Imperagen in Artificial Intelligence and Manchester

Companies Similar to Imperagen

Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…

Series B $76.0M

Callosum provides data analytics, artificial intelligence, and digital engineering services for data…

Seed $100M

Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…

Seed $8.0M

Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…

Series A $30.0M

Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…

Series A $9.0M

The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…

Series B

Malted AI is a company that designs a low-code platform that allows businesses to create and launch…

Seed $3.9M

OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…

Series B $312M

Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…

Series B $20.0M

Greyparrot is the leading AI waste analytics platform for the circular economy. We are on a mission to…

Series B $27.0M

Founded by Dr. Sam Tukra and Callum Adamson (who have been working together since 2019) in 2023 to solve the…

Series A $19.9M

1001 AI is a deep-tech artificial intelligence startup that develops AI infrastructure and…

Series A $30.0M

Imperagen Funding FAQs

What does Imperagen do?

Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.

How much funding has Imperagen raised?

Imperagen has raised $6.7M across 1 round on record. The most recent is a Seed of $6.7M announced in May 2026.

When did Imperagen last raise funding?

Imperagen's most recent funding round on record is a Seed of $6.7M, announced in May 2026.

Who founded Imperagen?

FundedIQ lists Guy Levy (Founder) at Imperagen.

Where is Imperagen headquartered?

Imperagen is based in Manchester, Manchester, United Kingdom.

How many employees does Imperagen have?

Imperagen is in the 11-50 employee band.

How does Imperagen's funding compare to other Artificial Intelligence startups?

Imperagen's latest round of $6.7M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Imperagen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Imperagen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.